#European Medicines Agency

A vial of the Johnson & Johnson Janssen Covid-19 vaccine at a vaccination center in Chicago, Illinois, on March 5, 2021. Photo: Kamil Krzaczynski / AFP
A vial of the Johnson & Johnson Janssen ... […]

Clot questions over J&J and AstraZeneca vaccines

The European Medicines Agency (EMA) says blood clots should be listed as a "very rare" side effect of the Johnson & Johnson COVID vaccine. What we know about the jab and similar AstraZeneca shot:
Based on the most recent data, someone getting the AstraZeneca vaccine stands a 1-in-153,000 chance of cerebral venous sinus thrombosis (CVST). Photo: Martin Bureau / AFP
Based on the most recent data, someone g... […]

AstraZeneca vaccine: what we know and what we don’t

A European Medicines Agency recommendation that a type of blood clot should be listed as a "very rare side effect" of the AstraZeneca jab stopped just short of saying there is a causal link with the vaccine
A medical worker gives the AstraZeneca Covid-19 vaccine to a patient at a vaccination centre in Vantaa, Finland, on March 11, 2021. Markku Ulander / Lehtikuva / AFP
A medical worker gives the AstraZeneca C... […]

Nordic countries play safe with AstraZeneca jab

Nordic countries were among the first to suspend use of AstraZeneca's Covid vaccine amid fears of side effects and, unlike most of the rest of Europe, they're holding off on resuming